Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of FLUAD-H5N1 Influenza Vaccine in Adults and Elderly
2006-005428-18Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Audenz in influenza (2 arms), sponsored by Novartis. Primary endpoint: Local reactogenicity after vaccination. Started Nov 2006; status: completed.
02
Drugs
Audenz
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-005428-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005428-18.